Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...
As H5N1 Is Detected In San Francisco, A Panel Discusses Next Steps
San Francisco confirmed that a child in the city became the first case of H5N1. A panel of biotech leaders discussed what ...
'Nobody really attends': Thousands come to SF for a conference and ignore the sessions
At an SF talk, JB Smoove told crowds he's nothing like Leon from "Curb Your Enthusiasm." Plus, a sprawling light-up Oakland ...
Fierce Healthcare1d
JPM25: Sutter Health strikes deal with GE HealthCare for AI imaging tech as it maps out ambitious expansion plans
GE HealthCare struck a seven-year agreement with Sacramento, California-based Sutter Health to provide AI-powered medical ...
NBC Los Angeles3d
GLP-1s and Brian Thompson's killing loom large at top health-care conference
This year’s JPMorgan health-care conference took place a month after UnitedHealthcare CEO Brian Thompson was fatally shot in ...
Evacuations lifted as massive Northern California lithium battery facility fire continues to burn
Authorities in Monterey County, California lifted all evacuations Friday night, one day after a fire broke out at one of the world's largest lithium battery storage facilities.
Less Swag, More Bodyguards as 2025 Industry Conferences Boost Security
In the wake of UnitedHealth CEO's sidewalk assassination, professional gatherings are boosting security and safety oversight for attendees.
STAT4d
A reporter’s JPM notebook: a look ahead for biopharma VC investing
What are biopharma VCs looking to invest in this year? Autoimmune disorders, osteoporosis, and cardiovascular disease are ...
C&EN4d
A ‘wait-and-see’ vibe dominates biotech’s biggest event of the year
This year will also doubtlessly bring deals involving artificial intelligence and related technologies. Experts predict that ...
FierceBiotech4d
'Own JP Morgan, don't let JP Morgan own you': Biopharma—and Jill Biden—show up for JPM25
This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties ...